BACKGROUND:Black and Latinx adults experience disproportionate asthma-related morbidity and limited specialty care access. The severe acute respiratory syndrome coronavirus 2 pandemic expanded telehealth use. OBJECTIVE:To evaluate visit type (telehealth [TH] vs in-person [IP]) preferences and the impact of visit type on asthma outcomes among Black and Latinx adults with moderate-to-severe asthma. METHODS:For this PREPARE trial ancillary study, visit type preference was surveyed by e-mail or telephone post-trial. Emergency medical record data on visit types and asthma outcomes were available for a subset (March 2020 to April 2021). Characteristics associated with visit type preferences, and relationships between visit type and asthma outcomes (control [Asthma Control Test] and asthma-related quality of life [Asthma Symptom Utility Index]), were tested using multivariable regression. RESULTS:A total of 866 participants consented to be surveyed, with 847 respondents. Among the participants with asthma care experience with both visit types, 42.0% preferred TH for regular checkups, which associated with employment (odds ratio [OR] = 1.61; 95% confidence interval [CI], 1.09-2.39; P = .02), lower asthma medication adherence (OR = 1.06; 95% CI, 1.01-1.11; P = .03), and having more historical emergency department and urgent care asthma visits (OR = 1.10 for each additional visit; 95% CI, 1.02-1.18; P = .02), after adjustment. Emergency medical record data were available for 98 participants (62 TH, 36 IP). Those with TH visits were more likely Latinx, from the Southwest, employed, using inhaled corticosteroid-only controller therapy, with lower body mass index, and lower self-reported asthma medication adherence vs those with IP visits only. Both groups had comparable Asthma Control Test (18.4 vs 18.9, P = .52) and Asthma Symptom Utility Index (0.79 vs 0.84, P = .16) scores after adjustment. CONCLUSION:TH may be similarly efficacious as and often preferred over IP among Black and Latinx adults with moderate-to-severe asthma, especially for regular checkups. TRIAL REGISTRATION:ClinicalTrials.gov Identifier: NCT02995733.

Introduction Black and Latinx patients bear a disproportionate burden of asthma-related morbidity partly due to inadequate healthcare access. Telehealth could improve access, but its impact on asthma outcomes compared to in-person visits in these populations is unknown. Methods Black and Latinx adults with moderate-severe asthma were recruited from US clinics, including Puerto Rico for the PREPARE trial. For this ancillary study, 7/19 sites had available EMR data on asthma care appointment setting (telehealth vs. in-person). Participants whose asthma care included telehealth (TH) vs. those with exclusively in-person visits (IP) starting at COVID-19 pandemic onset (3/2020, greater telehealth prevalence) through 4/2021 (last PREPARE exit) were included if 2+ monthly PREPARE surveys were available for the post-index visit period. Asthma control (ACT®) and asthma-related quality of life (ASUI) were compared between TH vs. IP. Results Data were available for n=62 TH and n=36 IP participants, with comparable duration of follow-up (6.36 vs. 6.42 months, respectively). TH were more likely Latinx, from the Northeast, employed, only use inhaled corticosteroids as controller therapy, lower BMI, and lower self-reported asthma therapy adherence compared to IP. Before and after adjustment for these baseline differences and for PREPARE treatment assignment and baseline ACT and ASUI scores, TH and IP had comparable follow-up asthma control (ACT 18.43 vs. 18.93, respectively, p=0.519) and asthma-related quality of life (ASUI 0.79 vs. 0.84, respectively, p=0.163). Conclusion Asthma control and asthma-related quality of life were comparable between TH and IP after adjustment. TH may represent a valuable asthma care option for Black and Latinx patients.

Introduction Little is known about the variability in chronic obstructive pulmonary disease (COPD) management and how it may be affected by patient characteristics across different healthcare systems in the US. This study aims to describe demographic and clinical characteristics of people with COPD and compare management across five primary care medical groups in the US. Methods This is a retrospective observational registry study utilizing electronic health records stored in the Advancing the Patient Experience (APEX) COPD registry. The APEX registry contains data from five US healthcare organizations located in Texas, Ohio, Colorado, New York, and North Carolina. Data on demographic and clinical characteristics of primary care patients with COPD between December 2019 and January 2020 were extracted and compared. Results A total of 17,192 patients with COPD were included in analysis: Texas (n = 811), Ohio (n = 8722), Colorado (n = 472), New York (n = 1149) and North Carolina (n = 6038). The majority of patients at each location were female (>54%) and overweight/obese (>60%). Inter-location variabilities were noted in terms of age, race/ethnicity, exacerbation frequency, treatment pattern, and prevalence of comorbid conditions. Patients from the Colorado site experienced the lowest number of exacerbations per year while those from the New York site reported the highest number. Hypertension was the most common co-morbidity at 4 of 5 sites with the highest prevalence in New York. Depression was the most common co-morbidity in Ohio. Treatment patterns also varied by site; Colorado had the highest proportion of patients not on any treatment. ICS/LABA was the most commonly prescribed treatment except in Ohio, where ICS/LABA/LAMA was most common. Conclusions and Relevance Our data show heterogeneity in demographic, clinical, and treatment characteristics of patients diagnosed with COPD who are managed in primary care across different healthcare organizations in the US.

PURPOSE:To describe demographic and clinical characteristics of chronic obstructive pulmonary disease patients managed in US primary care.METHODS:This was an observational registry study using data from the Chronic Obstructive Pulmonary Disease (COPD) Optimum Patient Care DARTNet Research Database from which the Advancing the Patient Experience COPD registry is derived. Registry patients were aged ≥35 years at diagnosis. Electronic health record data were collected from both registries, supplemented with patient-reported information/outcomes from the Advancing the Patient Experience registry from 5 primary care groups in Texas, Ohio, Colorado, New York, and North Carolina (June 2019 through November 2020).RESULTS:Of 17,192 patients included, 1,354 were also in the Advancing the Patient Experience registry. Patients were predominantly female (56%; 9,689/17,192), White (64%; 9,732/15,225), current/ex-smokers (80%; 13,784/17,192), and overweight/obese (69%; 11,628/16,849). The most commonly prescribed maintenance treatments were inhaled corticosteroid with a long-acting β2-agonist (30%) and inhaled corticosteroid with a long-acting muscarinic antagonist (27%). Although 3% (565/17,192) of patitents were untreated, 9% (1,587/17,192) were on short-acting bronchodilator monotherapy, and 4% (756/17,192) were on inhaled corticosteroid monotherapy. Despite treatment, 38% (6,579/17,192) of patients experienced 1 or more exacerbations in the last 12 months. These findings were mirrored in the Advancing Patient Experience registry with many patients reporting high or very high impact of disease on their health (43%; 580/1,322), a breathlessness score 2 or more (45%; 588/1,315), and 1 or more exacerbation in the last 12 months (50%; 646/1,294).CONCLUSIONS:Our findings highlight the high exacerbation, symptom, and treatment burdens experienced by COPD patients managed in US primary care, and the need for more real-life effectiveness trials to support decision making at the primary care level.

The Advancing the Patient Experience (APEX) in Chronic Obstructive Pulmonary Disease (COPD) registry (https://www.apexcopd.org/) is the first primary care health system-based COPD registry in the United States. While its ultimate goal is to improve the care of patients diagnosed with COPD, the registry is also designed to describe real-life experiences of people with COPD, track key outcomes longitudinally, and assess the effectiveness of interventions. It will retrospectively and prospectively collect information from 3000 patients enrolled in 5 health care organizations. Information will be obtained from electronic health records, and from extended annual and brief questionnaires completed by patients before clinic visits. Core variables to be collected into the APEX COPD registry were agreed on by Delphi consensus and fall into 3 domains: demographics, COPD monitoring, and treatment. Main strengths of the registry include: 1) its size and scope (in terms of patient numbers, geographic spread and use of multiple information sources including patient-reported information); 2) collection of variables which are clinically relevant and practical to collect within primary care; 3) use of electronic data capture systems to ensure high-quality data and minimization of data-entry requirements; 4) inclusion of clinical, database development, management and communication experts; 5) regular sharing of key findings, both at international/national congresses and in peer-reviewed publications; and 6) a robust organizational structure to ensure continuance of the registry, and that research outputs are ethical, relevant and continue to bring value to both patients and physicians.

Rationale: To improve COPD management in primary care, it is first necessary to describe these patients using clinically-relevant variables that can be collected practically and monitored longitudinally.Our aim was to describe the demographic and clinical characteristics of COPD patients managed in U.S. primary care. Methods: This is an observational, patient registry study using data from the COPD Optimum Patient care DARTNet Research Database (COPD-RD) from which the Advancing the Patient Experience (APEX) COPD registry is derived.The APEX in COPD registry is the first U.S. primary care, based registry, to collect both retrospective and prospective electronic health record (EHR) data and patient reported information/outcomes and plans to include 3,000 COPD patients.COPD patients included in the registry were aged ≥35 years at diagnosis with a COPD diagnosis code [ICD9CM, ICD10CM].Baseline demographic and clinical EHR data for all available patients were accessed (Dec 2019-Jan 2020) from 5 U.S. large primary care medical groups located in TX, CO, NC, OH and NY.Most data extend back as far as 2009.pg. 2 Results: Baseline data from 17,192 available patients (mean age (SD): 67.4 years (11.3)) were included.Patients were predominantly female (n=9,689/17,192; 56.4%), white (n=9,732/15,216; 56.6%), current-(n=6,428/17,192; 37.4%) and ex-smokers (n=7,356/17,192; 42.8%) and over-weight/obese (n=8,620/12,475; 69.1% ).Overall, 38.3% of patients (n=6,579/17,192) experienced ≥1 (acute lower respiratory event) in the last 12 months; 22.3%, 8.4% and 7.6% experienced 1, 2 and ≥3 exacerbations, respectively.Of those patients with a blood eosinophil count (BEC) reading (n=8,882/17,192; 51.7%) most had a BEC (ever) in the range 150-300 cells/µL (n=4,062/8,882; 45.7%) and >300 cells/µL (n=3,102/8,882; 34.9%).Overall, 2.9% of patients (n=494/17,192) received no therapy (last 12 months), 9.2% (n=1,587/17,192) were on short-acting bronchodilators only, 12.4% (n=2,127/17,192) were on LAMA, 13.2% (n=2,265/17,192) on LABA/LAMA, 5.7% (n=979/17,192) on ICS monotherapy, 28.9% (n=4,970/17,192) on ICS/LABA and 27.1% (n=4,658/17,192) on ICS/LAMA/LABA therapy.The most common comorbidities were hypertension (n=12,488/17,192; 72.6%), diabetes mellitus (7,724/17,192; 44.9%), depression (n=7,240/17,192; 42.1%), osteoarthritis (n=7,098/17,192; 41.3%), anxiety (n=5,403/17,192; 31.4%),obstructive sleep apnea (n=6,295/17,192; 36.6%),GERD (n=6,758/17,192; 39.3%), and asthma (5,713/17,192; 33.2%). Conclusion:These data comprehensively describe patients diagnosed with COPD managed in U.S. primary care, emphasizing the high exacerbation and co-morbidity burden.Approximately 20% of patients coded as COPD are not treated with correct maintenance medication.

The use of electronic health records allows for the application of a novel medication risk score for the rapid identification of ambulatory patients at risk of adverse drug events. We sought to examine the longitudinal association of medication risk score with mortality. This retrospective cohort study included patients whose data were available through electronic health records from multiple health care organizations in the United States that provided data as part of a Patient Safety Organization. Patients were included if they had ≥1 visit and ≥1 medication in their record between January 1, 2011, to June 30, 2017. Cox proportional hazards regression was used to examine the association between continuous and categorized medication risk score with all-cause mortality. Among 427,103 patients, the median age was 50 years (interquartile range, 29-64 years); 61% were female; 50% were White, 11% were Black, and 38% were Hispanic; and 6873 had a death date recorded. Patients 30 to 49 years old had the highest hazard ratios (HRs), followed by the 50- to 64-year-olds and lastly those 65 years or older. Controlling for all covariates, 30- to 49-year-olds with a score of 20 to 30 (versus <10) had a 604% increase in the hazard of death (HR, 7.04; 95% confidence interval [CI], 3.86-12.85), 50- to 64-year-olds had a 254% increase (HR, 3.54; 95% CI, 2.71-4.63), and ≥65-year-olds had an 87% increase (HR, 1.87; 95% CI, 1.67-2.09). The medication risk score was independently associated with death, adjusting for multimorbidities and other conditions. Risk was found to vary by age group and score. Results suggest that pharmaceutical interventions among those with elevated scores could improve medication safety for patients taking multiple medications.

AbstractObjectiveThe Farmers’ Market Fresh Fund Incentive Program is a policy, systems and environmental intervention to improve access to fresh produce for participants on governmental assistance in the USA. The current study examined factors associated with ongoing participation in this matched monetary incentive programme.DesignRelationship of baseline factors with number of Fresh Fund visits was assessed using Poisson regression. Mixed-effects modelling was used to explore changes in consumption of fruits and vegetables and diet quality.SettingSan Diego, California.SubjectsRecipients of Supplemental Nutrition Assistance Program (SNAP), Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and Supplemental Security Income (SSI) who attended participating farmers’ markets from 2010 to 2012 (n 7298).ResultsAmong those with participation for ≤6 months, factors associated with increased visits included reporting more daily servings of fruits and vegetables (F&V) at baseline, being Vietnamese or Asian/Pacific Islander, and eligibility because of SNAP/CalFresh or SSI (v. WIC). Among those who came for 6–12 months, being Asian/Pacific Islander, eligibility because of SNAP/CalFresh and enrolling in the autumn, winter or spring were associated with a greater number of Fresh Fund visits. Among those who came for >12 months, being male and eligibility because of SSI were associated with a greater number of visits. Overall, the odds of increasing number of servings of F&V consumed increased by 2 % per month, and the odds of improved perception of diet quality increased by 10 % per month.ConclusionsSustaining and increasing Fresh Fund-type programme operations should be a top priority for future policy decisions concerning farmers’ market use in low-income neighbourhoods.

This study examines the demographic representativeness of the County of San Diego Body Mass Index (BMI) Surveillance System to determine if the BMI estimates being obtained from this convenience sample of individuals who visited their healthcare provider for outpatient services can be generalized to the general population of San Diego. Height and weight were transmitted from electronic health records systems to the San Diego Immunization Registry (SDIR). Age, gender, and race/ethnicity of this sample are compared to general population estimates by sub-regional area (SRA) (n = 41) to account for regional demographic differences. A < 10% difference (calculated as the ratio of the differences between the frequencies of a sub-group in this sample and general population estimates obtained from the U.S. Census Bureau) was used to determine representativeness. In 2011, the sample consisted of 352,924 residents aged 2-100 years. The younger age groups (2–11, 12–17 years) and the oldest age group (≥65 years) were representative in 90, 75, and 85% of SRAs, respectively. Furthermore, at least one of the five racial/ethnic groups was represented in 71% of SRAs. This BMI Surveillance System was found to demographically represent some SRAs well, suggesting that this registry-based surveillance system may be useful in estimating and monitoring neighborhood-level BMI data.

Objectives: This study examines the cross-sectional associations of cognitive and physical function with life satisfaction in middle-class, community-dwelling adults aged 60 and older.Study design: Participants were 632 women and 410 men who had cognitive function tests (CFT) and physical function tasks (PFT) assessed at a clinic visit between 1988 and 1992, and who responded in 1992 to a mailed survey that included life satisfaction measures. Cognitive impairment was defined as <= 24 on MMSE, >= 132 on Trails B, <= 12 on Category Fluency, <= 13 on Buschke long-term recall, and <= 7 on Heaton immediate recall. Physical impairment was defined as participants' self-reported difficulty (yes/no) in performing 10 physical functions. Multiple linear regression examined associations between life satisfaction and impairment on >= 1 CFT or difficulty with >= 1 PFT.Main outcome measures: The Satisfaction with Life Scale (SWLS; range:0-26) and Life Satisfaction Index-Z (LSI-Z; range:5-35).Results: Participants' average age was 73.4 years (range = 60-94). Categorically defined cognitive impairment was present in 40% of men and 47% of women. Additionally, 30% of men and 43% of women reported difficulty performing any PFT. Adjusting for age and impairment on >= 1 CFT, difficulty performing >= 1 PFT was associated with lower LSI-Z and SWLS scores in men (beta = -1.73, -1.26, respectively, p < 0.05) and women (beta = -1.79, -1.93, respectively, p < 0.01). However, impairment on >= 1 CFT was not associated with LSI-Z or SWLS score after adjusting for age and difficulty with >= 1 PFT.Conclusions: Limited cognitive function was more common than limited physical function; however, limited physical function was more predictive of lower life satisfaction. Interventions to increase or maintain mobility among older adults may improve overall life satisfaction. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

Hypertension (HTN) is a modifiable risk factor for cardiovascular disease (CVD). Renal artery calcium (RAC) may signal the presence of flow-limiting atherosclerotic disease that may contribute to changes, in the kidney's regulation of blood pressure. We hypothesized that RAC is independently associated with HTN. We examined a multiethnic cohort of 1285 participants who underwent abdominal computed tomography scans in five US communities. After adjustment for age, gender, race/ethnicity, CVD risk factors, abdominal aortic calcium score, and kidney function, the presence of RAC was associated with a 50% higher odds of HTN (odds ratio: 1.54; 95% confidence interval 1.11-2.13). Similarly, the presence of RAC was associated with a 8.5 mm Hg higher systolic blood pressure, a 2.1 mm Hg higher diastolic blood pressure, and a 7.4-mm Hg higher pulse pressure. In conclusion, independent of CVD risk factors, abdominal aortic calcium, and kidney function, the presence of RAC is associated with HTN prevalence. (C) 2016 American Society of Hypertension. All rights reserved.